EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Vasoconstriction-inhibiting factor: an endogenous inhibitor of vascular calcification as a calcimimetic of calcium-sensing receptor

Sofía de la Puente-Secades iD, Dustin Mikolajetz iD, Nathalie Gayrard, Juliane Hermann, Vera Jankowski, Shruti Bhargava, Amina Meyer, Àngel Argilés iD, Turgay Saritas iD, Emiel P C van der Vorst iD, Zhuojun Wu, Heidi Noels iD und 9 weitere

Cardiovascular Research · 2025

DOI: 10.1093/cvr/cvaf016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Sofía de la Puente-Secades und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Cardiovascular Research (IMCAR), University Hospital RWTH Aachen, Pauwelsstraße 30, Aachen 52074, Germany. Hauptthemen laut MEDLINE: Vascular Calcification, Muscle, Smooth, Vascular, Receptors, Calcium-Sensing, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: German Research Foundation, European Union's Horizon, German Society of Internal Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Patients with chronic kidney disease (CKD) show a high risk of cardiovascular diseases, predominantly caused by accelerated vascular calcification. Vascular calcification is a highly regulated process with no current treatment. The vasoconstriction-inhibiting factor (VIF) peptide was recently discovered with vasoregulatory properties, but no information regarding calcification has been described. Methods and results In the present work, the inhibitory calcification effect of the VIF peptide was analysed in vitro in vascular smooth muscle cells (VSMCs), ex vivo in rat aortic rings, as well as in vivo in rats treated with vitamin D and nicotine (VDN). The VIF peptide inhibits vascular calcification by acting as a calcimimetic for the calcium-sensing receptor, increasing carboxylated matrix Gla protein production and blocking the activation of calcification pathways. The VIF peptide decreased calcium influx, the production of reactive oxygen species, and the activation of multiple kinases in VSMCs. Furthermore, calcium deposition in the aortas of patients with CKD negatively correlates with the VIF peptide concentration. Moreover, we show the cleavage of the VIF peptide from chromogranin-A by ‘proprotein convertase subtilisin/kexin type 2’ and ‘carboxypeptidase E’ enzymes. In addition, ‘cathepsin K’ degrades the VIF peptide. The active site of the native 35 amino acid-sequence long VIF peptide was identified with seven amino acids, constituting a promising drug candidate with promise for clinical translation.

Conclusion

The elucidation of the underlying mechanism by which the VIF peptide inhibits vascular calcification, as well as the active sequence and the cleavage and degradation enzymes, forms the basis for developing preventive and therapeutic measures to counteract vascular calcification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular CalcificationMuscle, Smooth, VascularReceptors, Calcium-SensingMyocytes, Smooth MuscleCalcimimetic AgentsAortic DiseasesVasoconstrictionPeptide HormonesAnimalsHumansCells, CulturedMaleRenal Insufficiency, ChronicDisease Models, AnimalReactive Oxygen SpeciesAortaMatrix Gla ProteinCalcium-Binding ProteinsCalcium SignalingSignal Transduction

Stichwörter der Autor:innen

CKDCaSRVascular Calcificationinhibitorsmooth muscle cells

Substanzen

Receptors, Calcium-SensingCalcimimetic AgentsReactive Oxygen SpeciesMatrix Gla ProteinCalcium-Binding ProteinsPeptide Hormonesextracellular calcium cation-sensing receptor, rat

Autor:innen und Institutionen

  • Institute of Molecular Cardiovascular Research (IMCAR), University Hospital RWTH Aachen, Pauwelsstraße 30, Aachen 52074, Germany.
  • Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands.
  • Institut National de la Santé Et de la Recherche Médicale (INSERM), RD-Néphrologie and EA7288, Montpellier, France.
  • Institute of Experimental Medicine and Systems Biology, Division of Nephrology, University Hospital RWTH Aachen, Aachen, Germany.
  • Division of Nephrology and Clinical Immunology, University Hospital RWTH Aachen, Aachen, Germany.
  • Interdisciplinary Centre for Clinical Research (IZKF), University Hospital RWTH Aachen, Aachen, Germany.

ORCID-Profile: Sofía de la Puente-Secades, Dustin Mikolajetz, Àngel Argilés, Turgay Saritas, Emiel P C van der Vorst, Heidi Noels, Martin Tepel, Michael Wolf, Leon Schurgers, Joachim Jankowski

Förderung

  • German Research Foundation
  • European Union's Horizon
  • German Society of Internal Medicine
  • European Union’s Horizon

Zitieren

APA

de la Puente-Secades, S., Mikolajetz, D., Gayrard, N., Hermann, J., Jankowski, V., Bhargava, S., Meyer, A., Argilés, À., Saritas, T., van der Vorst, E. P. C., Wu, Z., Noels, H., Tepel, M., Alghamdi, K., Ward, D., Zidek, W., Wolf, M., Floege, J., Schurgers, L., …, & Jankowski, J. (2025). Vasoconstriction-inhibiting factor: an endogenous inhibitor of vascular calcification as a calcimimetic of calcium-sensing receptor. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf016

Vancouver

de la Puente-Secades S, Mikolajetz D, Gayrard N, Hermann J, Jankowski V, Bhargava S, et al. Vasoconstriction-inhibiting factor: an endogenous inhibitor of vascular calcification as a calcimimetic of calcium-sensing receptor. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf016

BibTeX
@article{delaPuenteSecades2025,
  author = {de la Puente-Secades, Sofía and Mikolajetz, Dustin and Gayrard, Nathalie and Hermann, Juliane and Jankowski, Vera and Bhargava, Shruti and Meyer, Amina and Argilés, Àngel and Saritas, Turgay and van der Vorst, Emiel P C and Wu, Zhuojun and Noels, Heidi and Tepel, Martin and Alghamdi, Khaleda and Ward, Donald and Zidek, Walter and Wolf, Michael and Floege, Jürgen and Schurgers, Leon and Orth-Alampour, Setareh and Jankowski, Joachim},
  title = {Vasoconstriction-inhibiting factor: an endogenous inhibitor of vascular calcification as a calcimimetic of calcium-sensing receptor},
  journal = {Cardiovascular Research},
  year = {2025},
  doi = {10.1093/cvr/cvaf016}
}
Kostenlos starten →